SEC Form 4 · accession 0001127602-18-026803
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hooman Hakami
Officer — EVP & Group President Diabetes
Period of report
Aug 31, 2018
Accepted (ET)
Sep 5, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 31, 2018 | M | 399 | $62.76 | A | 63,046 | D | |
| Ordinary Shares | Aug 31, 2018 | M | 7,436 | $62.76 | A | 70,482 | D | |
| Ordinary Shares | Aug 31, 2018 | M | 18,324 | $62.76 | A | 88,806 | D | |
| Ordinary SharesF2 | Aug 31, 2018 | S | 26,159 | $96.288 | D | 62,647 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $62.76 | Aug 31, 2018 | M | 399 | D | — | Jul 28, 2024 | Ordinary Shares | 399 | 0 | D |
| Stock Option (Right to Buy)F3 | $62.76 | Aug 31, 2018 | M | 7,436 | D | — | Jul 28, 2024 | Ordinary Shares | 7,436 | 0 | D |
| Stock Option (Right to Buy)F3 | $62.76 | Aug 31, 2018 | M | 18,324 | D | — | Jul 28, 2024 | Ordinary Shares | 18,324 | 0 | D |
Explanation of responses
- F1The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.04 to $96.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant.